Podcasts about pharmaceutical

Plus, South Korea says it's preparing roughly $23 billion in government support for the chip sector amid tariff uncertainty. And Netflix aims for a $1trillion market capitalization. Luke Vargas hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Are we on the brink of a major shift in research? In this episode of Sounds of Science, Charles River experts challenge traditional approaches, exploring cutting-edge innovations that enhance animal welfare while driving scientific breakthroughs.   From revolutionary non-animal testing methods to advanced behavioral management strategies, we uncover how ethical care leads to better data and faster drug discovery. Tune in to discover how science, compassion, and innovation are shaping the next era of drug development.Show Notes Animals in Research | 3Rs Alternative Methods Advancement Project CHARTER Program for Lab Animal Welfare Advancing Responsible Science 

On this week's episode of The Debrief Weekly Report, Kenna and Steph, along with their feline producer, Beemo the Cat, run far far far far away from the "psycho salmon" that seem to be appearing due to pharmaceutical pollution in waterways. Next they play with some 3D holograms that have becoming interactive, and taste the latest research into 'digital flavour." Every Tuesday, join hosts Stephanie Gerk, Kenna Hughes-Castleberry, and MJ Banias as they round up the latest science and tech stories from the pages of The Debrief. From far-future technology to space travel to strange physics that alters our perception of the universe, The Debrief Weekly Report is meant for the dreamers who love the science and technology of the future. Follow the Debrief on X: https://twitter.com/Debriefmedia Follow Stephanie Gerk on X: https://twitter.com/stephgerk Follow Kenna Hughes-Castleberry on X: https://twitter.com/kennaculture Have something to tell us? Email the show at weeklyreport@thedebrief.org

Episode 2630: Vinnie Tortorich speaks to Dr. Anthony Jay and they discuss items from plastics to genetics, misrepresentation in the media, and more. https://vinnietortorich.com/2025/04/from-plastics-to-genetics-dr-anthony-jay-episode-2630 PLEASE SUPPORT OUR SPONSORS YOU CAN WATCH ALL THE PODCAST EPISODES ON YOUTUBE -  From Plastics to Genetics Dr. Anthony Jay was first on Fitness Confidential back in 2017. (2:00) His book can be purchased in Vinnie's Book Club: Estrogeneration: How Estrogenics Are Making You Fat, Sick, and Infertile (Chagrin and Tonic Series)   He is a researcher and geneticist and the information he wrote in the book is finally being discussed on a larger scale. BPAs don't always mean less harmful; BPS, phthalates, and other chemicals are substituted and can still be an issue. (5:30) The United States allows materials in products and food that are banned in Europe. (8:00) Pharmaceutical companies don't have to release studies, and what they do release is often cherry-picked data presented to the media. Burning carbs for energy means autophagy is not happening. (18:00) Health and genetics play a part in an individual's response to a virus. (23:30) Dr. Jay is a genetic researcher and consultant who helps people pinpoint possible genetic origins of health issues and helps them make changes based on data. They discuss the progression of COVID-19 and the mandates that came along with it. (31:00) The media and pharmaceutical corporations often use fear-mongering tactics and mishandle information. (40:00) Hope and Possibilities Anthony is hopeful that RFK, Jr. will make improvements in the health system, like getting crap out of infant formula. (47:15) What is Dr. Jay's opinion on raw milk? (51:30) Some people are highly sensitive to dairy and generally need to stay away from all dairy; however, others can have raw dairy and not have an issue. Between raw and pasteurized, Anthony personally prefers raw milk and he sources it from a local dairy that he trusts. Conventional milk can have emulsifiers in it to keep it from separating, but emulsifiers are horrible for your health. Emulsifiers are tasteless detergents that weaken your gut lining. (57:30) 23andMe and DNA testing. (1:00:00) Dr Jay is a genetic consultant who can help you see what health needs you may have. (1:00:00) If you decide to use the services that analyze your DNA, you can often opt out of sharing your information. Dr. Jay can give you health insights consultation based on your genetic data. You can do so by contacting him through his website. If you have used a service like 23andMe, Ancestry, MyHeritage, or SelfDecode, and have access to your raw data file, he will be able to help. More News If you are interested in the NSNG® VIP group, closed for registration, but you can get on the wait list - Don't forget to check out Serena Scott Thomas on Days Of Our Lives on the Peacock channel.  “Dirty Keto” is available on Amazon! You can purchase or rent it . Make sure you watch, rate, and review it! Eat Happy Italian, Anna's next cookbook is available!  You can go to  You can order it from .  Anna's recipes are in her cookbooks, website, and Substack–they will spice up your day!  Don't forget you can invest in Anna's Eat Happy Kitchen through StartEngine.  Details are at Eat Happy Kitchen.  There's a new NSNG® Foods promo code you can use! The promo code ONLY works on the NSNG® Foods website, NOT on Amazon. https://nsngfoods.com/   PURCHASE  DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere:  Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere:  REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere:  FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: 

00:00:00 - Bizarre Manager Tales and Alex Jones Clips Show opens with banter about Joe's intense management style and new gig. A selection of wild Alex Jones clips is played, prompting commentary on his chaotic delivery. Brief update on financial markets and some humorous talk about waffles and economic indicators. 00:10:00 - Trump's Tariffs and Global Trade Drama Trump enacts 125% tariffs on China, sparing other nations temporarily. Discussion on whether the goal is to isolate China or encourage wider global cooperation. Kevin O'Leary's call for 400% tariffs sparks debate about fairness and enforcement. 00:20:00 - China Retaliates and Trade War Escalates China responds with 84% retaliatory tariffs, calling for global unity against Trump. Memes and viral videos mocking American factory jobs are discussed. Hosts defend blue-collar work and examine why jobs were offshored post-NAFTA. 00:30:00 - Political Rage and Brain Circuitry New study links political extremism to specific brain circuits. Hosts joke about future pharmaceuticals to dull political emotions, like a “political Prozac.” Pharmaceutical industry's potential to profit off this condition is debated. 00:40:00 - CE-5 UFO Summoning and Sky Jellyfish Jake Barbour's team claims to psychically summon UFOs using CE-5 protocols. Descriptions of “Class 7” jellyfish-like UFOs that pulse and float intelligently. Mick West's debunking dismissed, with debate on whether these are balloons or something more. 00:50:00 - New Jersey Drone Mystery and FAA Denials Claims of anomalous drone behavior over New Jersey in December 2024. FAA reportedly unaware of or uninvolved in some sightings, raising suspicions. Speculation of government cover-ups and comparisons to historic UAP sightings. 01:00:00 - Restaurant Scammers and Ark Excavation Father and son duo scam over 100 French restaurants using fake card/ID trick. Scheme included pretending cards didn't work and leaving IDs they later replaced. Quick note that another attempt is underway to dig up Noah's Ark. 01:10:00 - Disturbing Teacher Abuse and Funeral Fails Shocking story of a teacher inappropriately involved with a special-needs student, also involving drugs and a murder plot. Shift to humorous but unfortunate funeral accident where pallbearers fall into a grave. Referenced comedy sketch “Coffin Flop” adds levity to an awkward moment. 01:20:00 - Middle-Aged Men Trading Cards in Japan Japanese trading card craze features real-life elderly men as collectible characters. Discussion on creating an American version featuring “Ohio Man” and regional archetypes. Hosts express genuine excitement and support for the quirky collectible concept. 01:30:00 - Urine Revenge and Tech Troubles A man throws bottles of urine at a business that denied him a job interview. Mike vents frustration about TeeSpring withholding merch funds, delaying tech upgrades. Conversation shifts toward moving to a new platform for merchandise fulfillment. 01:40:00 - Pee Tossing Fallout and David Paulides Kickstarter Extended jokes about urine-throwing suspect and weird job interview tactics. Update on David Paulides' successful Kickstarter for a new Missing 411 film. Mike reveals he won't receive his merch funds in time to upgrade his gear due to delays from TeeSpring. 01:50:00 - Mac Mini Upgrades and Japanese Card Economics Mike talks about upgrading his studio with a new Mac Mini to support soundboards. More commentary on Japanese middle-aged trading cards, including pricing, popularity, and potential U.S. parallels. Hosts suggest capitalizing on the trend with an American version featuring local archetypes.   Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research ▀▄▀▄▀ CONTACT LINKS ▀▄▀▄▀ ► Phone: 614-388-9109 ► Skype: ourbigdumbmouth ► Website: http://obdmpod.com ► Twitch: https://www.twitch.tv/obdmpod ► Full Videos at Odysee: https://odysee.com/@obdm:0 ► Twitter: https://twitter.com/obdmpod ► Instagram: obdmpod ► Email: ourbigdumbmouth at gmail ► RSS: http://ourbigdumbmouth.libsyn.com/rss ► iTunes: https://itunes.apple.com/us/podcast/our-big-dumb-mouth/id261189509?mt=2   - Affiliates Links - Jackery:  https://shrsl.com/3cxhf Barebones:  https://bit.ly/3G38773  Buy Tea! Mike's wife makes some good tea: Naked Gardener Teas: https://www.thenakedgardener.us/store Bags Art Store: https://www.redbubble.com/people/BagsDraws/  

China is fast becoming a major player in the global pharmaceutical and biotech industries. Once focused primarily on generic and me-too drugs, Chinese companies are now making headlines with innovative breakthroughs in oncology and gene therapy. Foreign investors are taking notice, pouring billions into partnerships and research projects across the country. But can China maintain this momentum — or will political pressure and consumer skepticism slow things down? Skip Montreux and Dez Morgan explore how China's pharmaceutical and biotech sectors are reshaping the global healthcare landscape. They trace the industry's evolution from state-run factories to world-class R&D centers, discuss the surge in foreign investment, and introduce key players like Akeso Biopharma. Along the way, they also unpack some of the challenges that may lie ahead for this fast-growing industry. Their conversation is a great learning resource if you want to build your English listening comprehension skills and expand your business vocabulary. Key points of their discussion include: The difference between pharmaceuticals and biotech — and where they overlap. The rise of Chinese firms like Akeso Biopharma and their potential to rival Western Big Pharma. Key challenges facing the sector, including domestic reputation issues and foreign policy risk. Do you like what you hear? Become a D2B Member today for to access to our -- NEW!!!-- interactive audio scripts, PDF Audio Script Library, Bonus Vocabulary episodes, and D2B Member-only episodes. Visit d2benglish.com/membership for more information. Follow Down to Business English on Apple podcasts, rate the show, and leave a comment. Contact Skip, Dez, and Samantha at downtobusinessenglish@gmail.com Follow Skip & Dez Skip Montreux on Linkedin Skip Montreux on Instagram Skip Montreux on Twitter Skip Montreux on Facebook Dez Morgan on Twitter RSS Feed

Send us a textThis podcast originally ran on October 21, 2023.This week we get down to basics, and basics are exactly what we need in this confusing world right now. This is THE podcast to listen to if you are confused about all things to do with taking hormone therapy.Dr Vikram Sinai Talaulikar is a specialist in reproductive medicine at University College London Hospital's NHS Foundation Trust and an associate professor in Women's Health at the University College London. He graduated in medicine in India in 2003 and completed a postgraduate degree in obstetrics and gynecology in 2007. He is a certified menopause specialist by the British Menopause Society, a menopause trainer and he is constantly educating others on this transition as well, via online webinars, events and through social media. He is also part of the trio who established the Menopause Research Education Fund, alongside medical journalist Fiona Clarke and groundbreaking menopause campaigner Diane Danzebrink.Highlights of our discussion: Hormone therapy (HT) 101WHI: good, bad and what we can learn from it 20 years onEstrogen in the pill vs estrogen in HT All the kinds of estrogen and what they are used for strogen too ethinyl estradiolEstrone, Estriol, Estradiol, and Estetrol.17 beta estradiolGetting to the bottom of body simila, body identical and bioidentical – and why that varies from country to country Pharmaceutical company produced HT vs compounding pharmacy versionsthe big “Catch-22” with compounding pharmacies that keeps their bioidentical hormones out of official recommendationsthe pill, HRT and breast cancer riskwhy problems with the pill don't get flagged and HRT does Evidence over estrogen and breast cancer risk (and randomized trials versus observational data)What's what: progesterone, progestin and progestogens (how they work and which one carries a slight risk for breast cancer)how long you really need to take HRT to see if it's workingwhy HT works for some people and not othersDr Talaulikar's favourite non-hormonal treatmentsWhere to find Dr Talaulikar:X: @VikramSinai Web: Menopause Clinic LondonMenopause Research and Education FundThe Living in Clarity Podcast, with Fish & Coach Do you want to live an awesome life and to also inspire others? Fish is a world...Listen on: Apple Podcasts SpotifyJoin the Hotflash inc perimenoposse: Web: hotflashinc.comNewsletter: Hotflash inc. on SubstackTikTok: @hotflashincInstagram: @hotflashincX: @hotflashinc Episode website: Hotflashinc Listen on: Apple Podcasts | Spotify | Google Podcasts | YouTube | Substack See hotflashinc.com/privacy-policy for privacy information

The Green Impact Report Quick take: Packaging and sustainability expert Tom shares how AI and smart technology are transforming recycling and landfill diversion efforts in stadiums, universities, and corporate buildings – creating a more engaging path to sustainability for the next generation. Meet Your Fellow Sustainability Champion  Thomas (Tom) Grinnan is a Global executive and consultant who thrives in new markets, leveraging 25+ years in the Pharmaceutical, Life Science & Packaging industries. With a strong background in sustainable packaging innovation, he's now leading DC1 as CEO, where they develop AI-powered solutions to drive recycling and reduce landfill waste. At DC1, Tom is focusing on landfill diversion through innovative technology that makes recycling more accessible, measurable, and engaging for users while providing valuable sustainability metrics for organizations. Tom began his career in strategic planning after studying French and biology at the University of Virginia. His multilingual skills (fluent in French with knowledge of Spanish, Japanese, and German) helped him develop a niche in cross-border market expansion. Throughout his career, Tom has grown businesses by 15%+ annually through strategic innovation and mentoring. Prior to joining DC1 in March 2024, he worked with major corporations like Midwest, Faco, Westrock, and Silgan, where he gained firsthand experience in sustainable manufacturing practices that reuse resources and minimize environmental impact.

Join Dr. John Abramson and Robert Whitaker as they evaluate the trustworthiness of clinical trials and medical data. Understand the importance of reliable data in making informed health decisions. #ClinicalTrials #MedicalData #HealthEvidence

On this episode, associates discuss the Senate Bill 150 - the Affordable Prescriptions for Patients Act of 2023.

In this episode, we share a recast of episode 302 where HeHe chats with Alexandra, the founder of Just The Inserts, to discuss the crucial topic of informed consent in pregnancy and pediatric care. With the current measles outbreak, it's more important than ever for parents and professionals to understand informed consent in the context of vaccines. Alexandra shares her journey in advocating for informed consent, the importance of reading pharmaceutical inserts, and navigating the complexities of the healthcare system. Whether you're an expecting parent or looking to make informed medical decisions for your family, this episode provides invaluable advice and resources. Don't miss Alexandra's tips on how to understand medical options, ensure safety, and feel confident in your healthcare choices. 00:00 Welcome to the Birth Lounge Podcast 00:48 Introducing the Host and Podcast Purpose 11:07 Diving into the Vaccine Debate 13:20 Navigating Medical Decisions and Providers 20:14 Understanding Informed Consent 25:13 The Importance of Reading Medical Inserts 31:40 Resources for Learning About Medical Inserts 34:00 Understanding the Bolded Parts 34:28 Introducing the New Book 35:12 Empowering Medical Decisions 37:04 The Importance of Vaccine Inserts 40:25 Concerns About Adverse Reactions 43:44 Transparency in Medical Information 47:51 State Laws and Medical Freedom 56:46 Resources for Informed Consent Guest Bio: Alexandra is the visionary behind Just the Inserts, a resource dedicated to empowering individuals and families with clear, accessible information about medical choices. With a background steeped in research and a commitment to transparency, Alexandra has become a trusted voice in the informed consent community, helping countless people navigate the complex world of medical information.   BIRTH EDUCATION: Get the free class to help you avoid a c-section and reduce your risk of tearing!    Join The Birth Lounge here for judgment-free childbirth education that prepares you for an informed birth and how to confidently navigate hospital policy to have a trauma-free labor experience!   Download The Birth Lounge App for birth & postpartum prep delivered straight to your phone! INSTAGRAM: Connect with HeHe on IG: https://www.instagram.com/tranquilitybyhehe/ Connect with Alexandra on IG: https://www.instagram.com/justtheinserts/ LINKS MENTIONED: https://www.justtheinserts.com/ https://www.ncbi.nlm.nih.gov/ Grab Alexandra's book, Well Considered, here: https://justtheinserts.store/

Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world.Pharmaceutical companies are pushing back against Trump's tariffs, requesting staggered tariffs as Trump plans for a more aggressive set of tariffs on April 2. Democrats are criticizing Trump's health cuts and policies, with lawsuits being filed and Senator Cory Booker speaking out against the administration. The FDA is facing turnover and layoffs, with concerns about the "revolving door" of talent between the agency and biopharma companies. Denali is making progress in crossing the blood-brain barrier for neuroscience treatments. In the midst of these developments, the biotech industry is seeing growth in cell and gene therapy investments. Despite these challenges, companies like Trilink are offering solutions for accelerating therapy discoveries with custom guide RNAs for CRISPR workflows.In other news, Peter Marks, head of the FDA's Center for Biologics Evaluation and Research, was forced out after clashing with Health and Human Services Secretary Robert F. Kennedy Jr. over transparency issues. Marks, known for his work on innovative therapies like cell and gene therapy, resigned due to the lack of desired truth and transparency from Kennedy. This event has caused turmoil in the biopharma industry, leading to a drop in biotech shares. Additionally, massive layoffs are expanding across HHS as part of Kennedy's plan to remove up to 10,000 staff members. The departure of Marks has raised concerns about the future of the FDA and the industry as a whole. Experts fear that the agency is losing institutional knowledge and experienced leaders, which could have negative implications for drug development and safety. Calls for Kennedy's dismissal have been made by analysts following Marks' resignation. The industry is now facing uncertainty and instability in the wake of these events.

அடி வாங்கிய IT Sector மீளுமா,வீழுமா, Pharmaceutical பங்குகள் விலை ஏற இதுதான் காரணம் Gold, Silver விலை சரிவுக்கு காரணம் என்ன, பலத்த சரிவில் IT Sector பங்குகளின் விலை Trump Tariff காரணமா போன்ற பல விஷயங்களை இந்த வீடியோவில் பேசியிருக்கிறார் வ.நாகப்பன்.

Welcome to Season 2 of the "We're All Screwed Up (and that's OK)" podcast - A Time Travellers Podcast. Episode 2: A conversation with David Hamilton. David Hamilton is an author of 13 books, including his recent

As we hear of the volcanic and seismic activity taking place in Iceland this week, pharmaphorum turns back to a conversation with Dean Alms, CPO of Aravo, on how extreme weather highlights the need to make adequate supply chain preparations for the seasons in which the planet pulls out all the stops with the worst of its natural disasters. Having a blueprint for supply chain resiliency is critical, as a mature and robust risk programme enables the right emergency protocols and drug reserves to be in place in the worst-case scenarios, and permits plants to return to full operation as speedily as possible. And this is where Aravo, a third-party management software solutions company, comes in, operating at three macro levels: life cycle management, the due diligence process, and providing unified visibility into all this information. Alms talks through the different scenarios and ways of approach to best safeguard the pharmaceutical supply chain, and explains what should be top of mind for chief risk officers when each extreme weather season arrives. You can listen to episode 171a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series - in iTunes, Spotify, Amazon Music, Podbean, and pretty much wherever you get your other podcasts!

When we hear the word technology, we tend to think about computers, software, artificial intelligence, etc. But one form of technology that we tend to overlook has been a part of our lives for centuries: pharmacy.Jeffrey Bishop, MD, Ph.D, Tenet Endowed Chair of Bioethics and Professor of Philosophy, Health Care Ethics and Philosophy at St. Louis University, joins the show to discuss how we can think critically about pharmaceuticals as technology. He discusses the etymology of the word "pharmacy," shares how power dynamics play into the decisions we make and offers advice on how to make sound, informed decisions about the drugs we take.

Did you know that the first attempt at a cancer vaccine was all the way back in the 1800s? I am joined by Charles River experts Louise Brackenbury, Dan Rocca, and Mike Templin to discuss the fascinating science behind therapeutic cancer vaccines.

Listen in as our expert panel discusses which diabetes meds have cardiovascular (CV) benefits.  We'll review the evidence and discuss the pros and cons of SGLT2 inhibitors (dapagliflozin, empagliflozin, etc) and GLP-1 agonists (dulaglutide, semaglutide, etc) in patients with or at risk for CV disease.Special Guests:Lauren G. Pamulapati, PharmD, BCACPAssociate Professor, Ambulatory CareVirginia Commonwealth University School of PharmacyClinical Pharmacist, Hayes Willis Health Center/VCU HealthChristie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCPProfessor, Pharmacy PracticeDirector, PGY2 Ambulatory Care Residency ProgramMidwestern University College of Pharmacy, Downers Grove CampusClinical Pharmacist, Northwestern MedicineTRC Editorial Advisory Board Participant:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleFor the purposes of disclosure, Dr. Schumacher reports a relevant financial relationship [CGM for diabetes management] with Abbott (speakers bureau).The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in February 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Diabetes Medications: Cardiovascular and Kidney ImpactChart: Drugs for Type 2 Diabetes Algorithm: Stepwise Treatment of Type 2 DiabetesChart: Comparison of GLP-1 AgonistsToolbox: Improving Heart Failure CareSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Yet Khor about the generalisability of pharmaceutical randomised controlled trial eligibility criteria for progressive pulmonary fibrosis.

Send us a message with this link, we would love to hear from you. Standard message rates may apply.The meteoric rise in demand for weight loss drugs has created widespread shortages, leading to the emergence of compounding pharmacies as an alternative source for these medications.• Compounding pharmacies create custom medications by combining, mixing, or altering ingredients to meet specific needs• Unlike FDA-approved medications, compounded drugs don't undergo the same rigorous safety and effectiveness reviews• Dosing errors with compounded weight loss medications have led to serious adverse events requiring hospitalization• Confusion between units, milliliters, and milligrams contributes to potentially dangerous dosing mistakes• Some compounding pharmacies add unproven ingredients like vitamins, L-carnitine, and NAD to their formulations• The long half-life of these medications (about one week) means overdose symptoms can persist for extended periods• Pharmaceutical companies have responded with direct-to-consumer models offering FDA-approved versions at reduced prices• Eli Lilly now offers Zepbound in vial form for approximately $499/month versus $1000+ for pen versions• Novo Nordisk's NovaCare pharmacy provides direct-to-patient delivery of Wegovy single-dose pens at similar price pointsPlease talk to your healthcare provider about what option might be right for you, as these medications require careful consideration and proper dosing is essential for safety.Support the showProduction and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

We're excited to welcome Oeystein Kjoersvik to AI Uncovered. Oeystein leads the Generative AI program within the Quality Assurance team at Merck, where he focuses on developing AI tools and applying a quality-first approach to ensure safe, effective use of AI in GxP-regulated environments.In this episode, Tim and Oeystein delve into the challenges of adopting AI in regulated settings, the complexity of validating GenAI tools, and the transition from traditional processes to AI-augmented systems. They also explore Oeystein's work with the IMPALA Consortium and the importance of cross-industry collaboration to identify and scale high-value use cases for Generative AI.Before his current role, Oeystein served as a Product Owner in Analytics at Merck IT, building analytics platforms and integrating data science across systems. He also contributed as a Machine Learning Subject Matter Expert to TransCelerate's Intelligent Automation Group, advancing AI applications in pharmacovigilance.Oeystein brings a rare blend of technical expertise and regulatory insight. He's passionate about helping teams adopt AI responsibly and transparently—ensuring innovation aligns with quality across the pharmaceutical landscape.Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team and uses his expertise to manage the wonderful world of product.

THE TIM JONES AND CHRIS ARPS SHOW 0:00 SEG 1 The Speaker's Stump Speech is brought to you by https://www.hansenstree.com/ and Ben Keathly, Rep. for MO District 101 and MO Freedom Caucus Co-Founder | with Tim in Jeff City | TOPIC: Missouri legislative session | Ben versus the Missouri Department of Transportation | Abortion and repealing amendment 3 | Pharmaceutical prices | Getting the income tax to 0 | “Income Tax is immoral” https://x.com/benKeath https://www.benkeathley.com/ 17:11 SEG 2 SUSIE MOORE, Deputy Managing Editor at RedState.com and host of RedState Radio, Sundays at 4pm | TOPIC: Elon is giving out $1 million checks in Wisconsin | Skinny on SCOTUS - The January Decisions | Mark Halperin joining the Megan Kelley podcast network | Jasmine Crockett makes AOC lookl like the sane onehttps://twitter.com/SmoosieQhttps://redstate.com/author/smoosieq 35:08 SEG 3 Chris watched “Kraven The Hunter” on Netflix https://newstalkstl.com/ FOLLOW TIM - https://twitter.com/SpeakerTimJones FOLLOW CHRIS - https://twitter.com/chris_arps 24/7 LIVESTREAM - http://bit.ly/NEWSTALKSTLSTREAMS RUMBLE - https://rumble.com/NewsTalkSTL See omnystudio.com/listener for privacy information.

THE TIM JONES AND CHRIS ARPS SHOW 0:00 SEG 1 The Speaker's Stump Speech is brought to you by https://www.hansenstree.com/ and Ben Keathly, Rep. for MO District 101 and MO Freedom Caucus Co-Founder | with Tim in Jeff City | TOPIC: Missouri legislative session | Ben versus the Missouri Department of Transportation | Abortion and repealing amendment 3 | Pharmaceutical prices | Getting the income tax to 0 | “Income Tax is immoral” https://x.com/benKeath https://www.benkeathley.com/ 17:11 SEG 2 SUSIE MOORE, Deputy Managing Editor at RedState.com and host of RedState Radio, Sundays at 4pm | TOPIC: Elon is giving out $1 million checks in Wisconsin | Skinny on SCOTUS - The January Decisions | Mark Halperin joining the Megan Kelley podcast network | Jasmine Crockett makes AOC lookl like the sane onehttps://twitter.com/SmoosieQhttps://redstate.com/author/smoosieq 35:08 SEG 3 Chris watched “Kraven The Hunter” on Netflix https://newstalkstl.com/ FOLLOW TIM - https://twitter.com/SpeakerTimJones FOLLOW CHRIS - https://twitter.com/chris_arps 24/7 LIVESTREAM - http://bit.ly/NEWSTALKSTLSTREAMS RUMBLE - https://rumble.com/NewsTalkSTL See omnystudio.com/listener for privacy information.

Donald Trump says he will attempt to get US pharmaceutical companies back from Ireland. It comes after the US President signed an executive order to impose a 25 per cent tariff on cars imported into the United States. He sees tariffs as a tool to raise revenue, to offset his promised tax cuts, and to revive a long-declining US industrial base. President Trump, who cited Ireland in his comments in the Oval Office, has his sights set on getting other companies back as well Tanaiste Simon Harris said Ireland was engaging with both EU and US To discuss this further, Alan Morrissey was joined by Tanaiste Simon Harris said Ireland was engaging with both EU and US, Kevin Thompstone.

US President Donald Trump has promised to put tariffs on pharmaceutical products coming into the country - specifically mentioning Ireland's large pharmaceutical industry.With 7 out of the world's top 10 pharmaceutical companies being based in the Rebel County, Newstalk Reporter Josh Crosbie has been speaking with workers in Cork to get their thoughts on what the future may look like, and joins Kieran to discuss.

Erin Fuse Brown is a professor of health services, policy, and practice at the Brown University School of Public Health and a member of the Journal's Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.C. Fuse Brown, O.J. Wouters, and A. Mehrotra. Partnerships between Pharmaceutical and Telehealth Companies — Increasing Access or Driving Inappropriate Prescribing? N Engl J Med 2025;392:1148-1151.

Hosts: Erin Rider and Taylor Morgan  Just turn on the TV for a bit, and you’re bound to see a drug advertisement that’s so common here in the United States. The U.S. and New Zealand are the only countries that allow drug companies to advertise directly to consumers, and it's a big business.  But they could be going away... if Director of Health and Human Services Robert F. Kennedy Jr. gets his way. Inside Sources discusses this possibility. 

It's a packed show with Deroy Murdock, Johnathan Butcher on education and Rep. Mike Bost on the show, and a lively discussion about culture in the 2:00 hour. It's the Annie Frey Show!

The Rich Zeoli Show- Hour 4: 6:05pm- Stacy Garrity—Pennsylvania Treasurer—joins The Rich Zeoli Show to discuss her new “Money Match” initiative which will automatically return unclaimed properties to thousands of Pennsylvanians. The checks total $1.7 million and are being mailed to an estimated 7,000+ PA residents. 6:30pm- According to what appears to be an erroneous report, Health and Human Services Secretary Robert F. Kennedy Jr. planned to ban pharmaceutical advertisements on television. Rich explains why this would be a bad idea—and likely a First Amendment violation. 6:40pm- On Tuesday, DNI Director Tulsi Gabbard, FBI Director Kash Patel, and CIA Director John Ratcliffe appeared before the Senate Intelligence Committee. During one notable exchange, Sen. Angus King (I-ME) bizarrely scolded Director Gabbard for removing climate change from a list of the most dangerous global threats. 6:50pm- During a Human Rights Campaign event, Congresswoman Jasmine Crockett (D-TX) referred to Texas Governor Greg Abbott as “governor hot wheels.” Gov. Abbott has used a wheelchair since an accident in 1984.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Sanofi has committed up to $1.9 billion to acquire Dren Bio's bispecific antibody for autoimmune disease, adding to its investments in the immunology portfolio. The deal comes after the tragic death of a patient who had taken the gene therapy Elevydys, prompting the Duchenne patient community to vow to push on. Paratek Pharmaceuticals has acquired Optinose for up to $330 million, while Senate Democrats demand the return of fired CDC staff. Sino Biological has developed recombinant antigens for the 2025-2026 influenza vaccine strains, and Purdue has filed for bankruptcy to support a $7.4 billion opioid settlement. Doctors continue to rally behind vaccines amidst doubts and misinformation, and Novartis' intrathecal Zolgensma has shown effectiveness in older children. TC Biopharm and Cargo have enacted steep workforce reductions. Pharmaceutical companies are also preparing for upcoming events, including webinars on AI regulation and drug development. Job opportunities in the pharmaceutical industry are available at companies like Takeda, Eli Lilly and Company, and Novo Nordisk.

Methylene blue (MB) has gained some massive exposure the last couple of months and is seemingly one of the hottest topics; and not just in biohacking and longevity circles, but even amongst general health and wellness enthusiasts. This exponential rise in MB is largely due to a handful of viral social media posts the last couple of months, which then prompted many influencers and/or medical professionals to voice their opinions and/or concern surrounding MB. There is some great info being circulated, but, needless to say, there is also a lot of misinformation being propagated.I wanted to take to the mic and address some of this misinformation and concern head-on. One issue that I see arise is around the quality of MB and, more specifically, the fact that MB can be derived from petroleum substances. Notice how I said, "can be." Yes, different industrial use cases may obtain their MB from petroleum-based sources, but is not the same MB that would be considered safe for human consumption. Also, there is a notion going around that you can make "homemade" leucomethyene blue simply be adding vitamin C to MB. I explain why this is a half-truth and does not lead to the same quality, purity, stability, bioavailability or effectiveness in mitochondria.The study covered in today's episode demonstrates how the mitochondria are being recognized as an integral therapeutic target for traumatic brain injuries (TBIs). That would mean  a.) mitochondrial dysfunction is a large part of the brain damage (and, thus, recovery) associated with TBIs and, presumably, other head trauma, such as concussions; and b.) anything that can improve mitochondrial function, particularly things that can positively affect the brain, has a large potential role to play in the recovery from TBIs and other head trauma. The Mitochondrial Triad ticks all of those boxes. If you found the information in today's episode particularly interesting and/or compelling, please share it with a family member, friend, colleague and/or anyone that you think could benefit and be illuminated by this knowledge. Sharing is caring :)As always, light up your health! - Key Points: 1:24 - Health Optimisation Summit Announcement4:06 - Return to Nature announcement5:56 - Methylene blue controversy7:40 - Qualities of Methylene Blue8:29 - Industrial Qualities of Methylene Blue9:08 - Pharmaceutical-grade Methylene Blue11:20 - Evaluating Methylene Blue as a consumer11:53 - Clear Methylene Blue13:09 - Vitamin C effect on Methylene Blue14:48 - Low-quality Methylene Blue vs. Pharmaceutical Grade17:46 - Methylene Blue + Vitamin C vs. Ultra-pure Pharmaceutical-Grade MB effectiveness22:16 - Tips for using Vitamin C Methylene Blue23:30 - Is there such a thing as too much antioxidant protection?25:12 - Do you own research/safety of methylene blue25:54 - Mitochondrial Dysfunction vs Anti-Synthetic sentiment26:36 - Will my Organs Turn Blue?27:55 - Ramifications of non-native EMFs30:02 - Toxicity of our Environment30:44 - Necessity of Improving Mitochondrial Function31:12 - Importance of Methylene Blue33:45 - Mitochondrial Therapy in Brain Injury40:31 - Final thoughts - Upcoming BioLight Events:   Health Optimisation Summit (Biohacking Conference), April 12 - 13 (Austin, TX)   Returning to Nature (Quantum Health Retreat), June 26 - 27 (Franklin, TN) - Articles referenced in episode:   Mitochondria as a Therapeutic Target: Focusing on Traumatic Brain Injury - Save 25% when you Subscribe & Save to a BioBundle!   For a BioBundle, you choose:1.) Any one BioBlue supplement(BioBlue, BioBlue (SR), BioBlue Leuco, BioBlue Calm, BioBlue Capsules or BioBlue Leuco Capsules)2.) Any one BioC60 supplement(Regular or Concentrated)   The BioBundle automatically saves you 15% on both of the supplements you choose.You save an additional 10% by choosing to Subscribe & Save to that BioBundle.The 25% savings is passed along for every monthly delivery of your BioBundle!No discount code necessary!   Click here to check out The BioBundle - Dr. Mike's #1 recommendations: Water products: Water & Wellness Grounding products: Earthing.com EMF-mitigating products: Somavedic Blue light-blocking glasses: Ra Optics - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

Today's Mystery: A druggist is murdered in front of Danny and the death is tied to a shooting and robbery at a Pharmaceutical plant.Original Radio Broadcast Date: April 28, 1950Originated in HollywoodStars: Larry Thor as Lieutenant Danny Clover, Charles Calvert as Sergeant Gino Tartaglia, Howard McNear, Paul McVey, Clayton Post, Sylvia Syms,Jeanette NolanGet 17% off your purchase of the Fulton Fish Market (I receive a commission)Support the show monthly at https://patreon.greatdetectives.netPatreon Supporter of the Day: Clarissa, Patreon Supporter since March 2024Support the show on a one-time basis at http://support.greatdetectives.net.Mail a donation to: Adam Graham, PO Box 15913, Boise, Idaho 83715Take the listener survey…http://survey.greatdetectives.netGive us a call 208-991-4783Follow us on Instagram at http://instagram.com/greatdetectivesBecome one of ourfriends on Facebook.Follow us on Twitter@radiodetectivesJoin us again tomorrow for another detective drama from the Golden Age of Radio.

Tune in as PwC's Pharmaceutical & Life Sciences Advisory Leader, Greg Rotz reflects on key market dynamics and explores how pharma leaders can tackle challenges including the $400 billion patent cliff, increasing competition, drug pricing pressures, and transformative disruptions shaping the industry. Discussion highlights:Understanding the scale and implications of the upcoming patent cliff and economic pressures from regulatory changes like the Inflation Reduction ActExamining heightened competition across therapeutic areas and the rapid emergence of rival treatments affecting market economicsHighlighting the necessity for bold strategic moves and critical capabilities, including AI innovation, portfolio optimization, strategic partnerships, and comprehensive risk managementAddressing disruptive forces such as geopolitical uncertainty, tariff impacts, and the rise of global innovation influencing pharmaceutical marketsEmphasizing the urgency for pharma leaders to embrace innovation and transformative strategies to improve healthcare affordability, accessibility, and qualitySpeakers:Greg Rotz, Pharmaceutical & Life Sciences Leader,PwCGlenn Hunzinger, Health Industries Leader, PwCJenny Colapietro, Consulting Commercial Leader, PwCLinked materials:Next in pharma 2025: The future is nowPharmaceutical and life sciences: US Deals 2025 outlookPresident Donald J. Trump's healthcare agendaFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Today's Mystery: A druggist is murdered in front of Danny and the death is tied to a shooting and robbery at a Pharmaceutical plant.Original Radio Broadcast Date: April 28, 1950Originated in HollywoodStars: Larry Thor as Lieutenant Danny Clover, Charles Calvert as Sergeant Gino Tartaglia, Howard McNear, Paul McVey, Clayton Post, Sylvia Syms,Jeanette NolanGet 17% off your purchase of the Fulton Fish Market (I receive a commission)Support the show monthly at https://patreon.greatdetectives.netPatreon Supporter of the Day: Clarissa, Patreon Supporter since March 2024Support the show on a one-time basis at http://support.greatdetectives.net.Mail a donation to: Adam Graham, PO Box 15913, Boise, Idaho 83715Take the listener survey…http://survey.greatdetectives.netGive us a call 208-991-4783Follow us on Instagram at http://instagram.com/greatdetectivesBecome one of ourfriends on Facebook.Follow us on Twitter@radiodetectives

Spheroids are three dimensional cell models that can mimic some organs, tumors, and other biological systems for drug testing. Like organoids and organs-on-a-chip, spheroids are breaking in to drug development as a promising alternative to animal models. I am joined by Madhu Lal Nag, MBS PhD from the 3D in vitro model company InSphero, to discuss the development and future potential of these tiny cellular machines.

Modern Wisdom: Read the notes at at podcastnotes.org. Don't forget to subscribe for free to our newsletter, the top 10 ideas of the week, every Monday --------- Brigham Buhler is a healthcare entrepreneur, founder and CEO of Ways2Well, and co-founder of ReviveRx Pharmacy. American healthcare stands apart from any other system in the world. While some argue it has the potential to be the best, for many, it feels like the worst. Sky-high costs, an overreliance on prescriptions, and systemic inefficiencies suggest something is deeply broken. Why is this the case, and what can be done to fix it? Expect to learn what the number one reason for bankruptcy in America is, what the average state of health is for the average American and how it compares to the rest of the world, why so many American's are on Pharmaceutical drugs, what drugs Americans are taking that are causing the most damage, what is happening with the Food industry's corporate capture of food, how much of an impact RFK can really have on changing the pharmaceutical and food system, the simple changes that can improve American healthcare and much more… Sponsors: See discounts for all the products I use and recommend: https://chriswillx.com/deals Get a Free Sample Pack of all LMNT Flavours with your first purchase at https://drinklmnt.com/modernwisdom Get $350 off the Pod 4 Ultra at https://eightsleep.com/modernwisdom (use code MODERNWISDOM) Get a 20% discount on Nomatic's amazing luggage at https://nomatic.com/modernwisdom Get the best bloodwork analysis in America at https://functionhealth.com/modernwisdom Extra Stuff: Get my free reading list of 100 books to read before you die: https://chriswillx.com/books Try my productivity energy drink Neutonic: https://neutonic.com/modernwisdom Episodes You Might Enjoy: #577 - David Goggins - This Is How To Master Your Life: https://tinyurl.com/43hv6y59 #712 - Dr Jordan Peterson - How To Destroy Your Negative Beliefs: https://tinyurl.com/2rtz7avf #700 - Dr Andrew Huberman - The Secret Tools To Hack Your Brain: https://tinyurl.com/3ccn5vkp - Get In Touch: Instagram: https://www.instagram.com/chriswillx Twitter: https://www.twitter.com/chriswillx YouTube: https://www.youtube.com/modernwisdompodcast Email: https://chriswillx.com/contact - Learn more about your ad choices. Visit megaphone.fm/adchoices

Artificial intelligence is getting a lot of attention these days, and many are wondering how it can be harnessed to help today's bakers. While it's too soon to understand the full extent of AI's capabilities, this technology is already being used to reduce product loss (https://bakerpedia.com/how-to-avoid-product-loss/), boost quality assurance (https://bakerpedia.com/food-safety/quality-assurance/), and much more in bakery plants. In this episode of BAKED in Science, host Mark Floerke is joined by five bakery experts to discuss the future of artificial intelligence in the baking industry and how it can be used to improve yield and productivity, as well as minimize waste in bakery plants. As a Certified Executive Coach with over 20 years in the bakery manufacturing industry, Dr. Lin Carson has pioneered the way for knowledge sharing through BAKERpedia. Starting with a BSc degree in Food Science & Technology from The Ohio State University, and a MSc and PhD from the Department of Grain Science at Kansas State University. She has led teams for bakery manufacturing companies like Wendy's International and Dave's Killer Bread. A career baker, Jim Little has more than 30 years of experience in a wide variety of products and production methods within the baking industry. Currently, he is the Senior Vice President of R&D and CI at CraftMark Bakery (https://www.craftmarkbakery.com) in Indianapolis, he has been challenged to develop an even deeper knowledge of formulation and production across frozen bread dough, cookies, muffins and flatbread. Yuegang Zhao is the Chief Commercial Officer for KPM Analytics (https://bakerpedia.com/kpm-analytics/), a global quality assurance and food safety solutions provider serving food, agriculture, and environmental industries. Yuegang has over 20 years of extensive global experience creating, developing, and growing enterprise value in various industries ranging from aerospace to fluid analysis. Phillip Stringer is the founder of Comprehensive Process Solutions, LLC (https://bakerpedia.com/comprehensive-process-solutions/), and an accomplished Engineering and R&D professional with 14 years of experience in the Food, Agriculture, and Pharmaceutical industries. His global expertise, gained from working in over 30 countries across six continents, equips him with a deep understanding of diverse client needs. Tremaine Hartranft, Vice President of Technical Growth and Strategy, is responsible for supporting the development of the vision, value and organizational structure at Reading Bakery Systems (https://www.readingbakery.com). Prior to joining Reading Bakery Systems, Tremaine worked at Brentwood Industries as a Research & Development Engineer, and at Lucent Technologies as a Process Analyst. How AI Can Help the Baking Industry Some topics covered include: Utilizing artificial intelligence to automate standard operating procedures Leveraging AI during the formulation process Vision inspection systems for improving quality The opportunity to use data for predictive maintenance Training AI to keep production standards up while experts are away The challenges of confidentiality around data sharing Developing an AI strategy for your bakery

Modern Wisdom Key Takeaways  The insurance companies and big pharma complex monetize chronic diseaseThey benefit if more Americans are chronically ill because it means more prescriptions and therefore more kickbacks and rebates Approximately 30% of the revenue generated from opioid abuse in America went to the big five insurance companies The insurance companies are incentivized to put you on drugs!About 60% of United Healthcare's annual revenue – $361 billion in 2024 – comes from prescription drugs via an entity called a pharmacy benefit manager The average American is on 4+ prescription drugs SSRIs are one of the most worrisome drugs of the day: A metaanalysis of over 75 studies revealed that 85% of the efficacy of an SSRI was related to placebo On a 52-point depression scale, SSRIs differentiate from placebo by 1-2 points The healthcare system is not broken; it is rigged, and the American taxpayer is the one footing the bill “Prescribing a GLP-1 without talking about diet, lifestyle, and nutrition is like brushing your teeth while eating Oreos.” – Brigham Buhler Behind age and smoking, the third biggest cause of chronic disease is metabolic diseaseTo fix the healthcare system, fixing metabolic health should be our primary focusWe have built an entire healthcare industry of siloed experts, but the body is one organism; we should adopt a more holistic approach to treatment Using AI to build a better system: We will use algorithmic-based medicine to take a proactive and predictive approach to medicine, which will reduce the onset of chronic disease immediately upon recognition Faster iteration phases between detection and intervention will improve our health Read the full notes @ podcastnotes.orgBrigham Buhler is a healthcare entrepreneur, founder and CEO of Ways2Well, and co-founder of ReviveRx Pharmacy. American healthcare stands apart from any other system in the world. While some argue it has the potential to be the best, for many, it feels like the worst. Sky-high costs, an overreliance on prescriptions, and systemic inefficiencies suggest something is deeply broken. Why is this the case, and what can be done to fix it? Expect to learn what the number one reason for bankruptcy in America is, what the average state of health is for the average American and how it compares to the rest of the world, why so many American's are on Pharmaceutical drugs, what drugs Americans are taking that are causing the most damage, what is happening with the Food industry's corporate capture of food, how much of an impact RFK can really have on changing the pharmaceutical and food system, the simple changes that can improve American healthcare and much more… Sponsors: See discounts for all the products I use and recommend: https://chriswillx.com/deals Get a Free Sample Pack of all LMNT Flavours with your first purchase at https://drinklmnt.com/modernwisdom Get $350 off the Pod 4 Ultra at https://eightsleep.com/modernwisdom (use code MODERNWISDOM) Get a 20% discount on Nomatic's amazing luggage at https://nomatic.com/modernwisdom Get the best bloodwork analysis in America at https://functionhealth.com/modernwisdom Extra Stuff: Get my free reading list of 100 books to read before you die: https://chriswillx.com/books Try my productivity energy drink Neutonic: https://neutonic.com/modernwisdom Episodes You Might Enjoy: #577 - David Goggins - This Is How To Master Your Life: https://tinyurl.com/43hv6y59 #712 - Dr Jordan Peterson - How To Destroy Your Negative Beliefs: https://tinyurl.com/2rtz7avf #700 - Dr Andrew Huberman - The Secret Tools To Hack Your Brain: https://tinyurl.com/3ccn5vkp - Get In Touch: Instagram: https://www.instagram.com/chriswillx Twitter: https://www.twitter.com/chriswillx YouTube: https://www.youtube.com/modernwisdompodcast Email: https://chriswillx.com/contact - Learn more about your ad choices. Visit megaphone.fm/adchoices

Whether you're a student, healthcare professional, or just curious about how medications work, our online community college pharmacology course has you covered. This 10-week, completely asynchronous course is designed to fit your schedule — no live sessions required. Learn at your own pace with flexible access to comprehensive content with weekly deadlines for course submission from May 20th to July 31st, 2025. In this practical course, you'll gain clear insights into: Pharmaceutical nomenclature and classification How drugs interact with the body — and each other Key indications, contraindications, and side effects Methods for administering therapeutic agents We'll dive deep into medications that treat conditions affecting the gastrointestinal, muscular, skeletal, respiratory, immune, nervous, cardiovascular, endocrine, and renal systems — plus much more. Past students have included pre-nursing, nursing, pre-PA, pharmacy, or just anyone looking to become a health professional.  Here are the links: www.MemorizingPharm.com www.MemorizingPharm.com/onlinepharmacologycourse  

In this podcast David Rendle discusses his paper 'Pharmaceutical treatment of equine glandular gastric disease: A contextualised review of recent developments'. 

How do you disrupt an entire industry and transform customer experience? Together with his team, TJ Parker, Co-Founder and former CEO of PillPack, did just that.During our conversation, TJ shares the journey of building PillPack, from their early vision and startup team, to navigating through extremely tense dynamics with very large incumbents, to ultimately selling PillPack to Amazon, and continuing to build for a much bigger market. He reflects on the biggest lessons learned, and also the most critical decisions that shaped the company's success.It was a treat to have TJ's big brother, Dan Parker, in the audience. When it came time for QA, Dan helpfully asked what percentage of college classes TJ actually attended.We also dive into the power of community, the importance of work ethic, and what's next for TJ in his new(er) role as an investor at Matrix Partners.Please like, rate, subscribe, or review our show if you've liked what you've heard! We'd love to hear your thoughts. If you're interested in joining our community, please visit www.breakline.org. If you're interested in exploring partnerships with BreakLine, please visit https://breakline.org/partners/partner-signup/.

Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. J&J has recently halted a late-stage depression trial due to lack of efficacy. Analysts do not believe this will have a significant impact on the company's broader neuroscience strategy. Meanwhile, there seems to be confusion at the FDA with terminations and reversals happening. In other news, Novo Nordisk has conducted limited studies on GLP-1s for addiction. Biogen and Eisai are facing setbacks with Leqembi overseas. There are potential FDA changes under commissioner Marty Makary. The FDA's priority review vouchers are in need of transparency. AstraZeneca has presented strong data for Imfinzi in stomach cancer. Atea Pharmaceuticals has made the decision to cut its workforce. Novo Nordisk is entering a legal battle against GLP-1 compounders, while Lilly has achieved a victory in a different matter. Pharmaceutical executives have recently shared insights on trust, technology, and the future at the WEF. Overall, there are various developments happening in the Pharma and Biotech industry that are worth keeping an eye on.

*The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.The practice of pharmaka, or preparation of biological ingredients into medicines or poisons, was once thought to be an act of sorcery or magic due to the way such things altered the body and mind. The word pharmaka comes from the Greek pharmakeia, meaning “practice of the druggist,” and is based on pharmakon, meaning “drug.” From the Greek we derive the words pharmacy, pharmaceutical, and pharmacology. Since men were traditionally hunters, the women would gather roots, herbs, flowers, and plants to cultivate powders, potions, and medicines. Pharmaceutical companies today are modern magicians using plants to alter the body and mind. The new use for a drug called Xolair, to limit allergic reactions, is the latest act of this sorcery. Although possibly life-saving, taking these drugs does not get to the root source of why we are allergic to this or that. The same can be said of the popular drug ozempic, or even over-the-counter anti-lactose pills. Ironically, one side-effect of Xolair is anaphylaxis!-FREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVEX / TWITTER FACEBOOKWEBSITECashApp: $rdgable EMAIL: rdgable@yahoo.com / TSTRadio@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/tst-radio--5328407/support.

Brigham Buhler is a healthcare entrepreneur, founder and CEO of Ways2Well, and co-founder of ReviveRx Pharmacy. American healthcare stands apart from any other system in the world. While some argue it has the potential to be the best, for many, it feels like the worst. Sky-high costs, an overreliance on prescriptions, and systemic inefficiencies suggest something is deeply broken. Why is this the case, and what can be done to fix it? Expect to learn what the number one reason for bankruptcy in America is, what the average state of health is for the average American and how it compares to the rest of the world, why so many American's are on Pharmaceutical drugs, what drugs Americans are taking that are causing the most damage, what is happening with the Food industry's corporate capture of food, how much of an impact RFK can really have on changing the pharmaceutical and food system, the simple changes that can improve American healthcare and much more… Sponsors: See discounts for all the products I use and recommend: https://chriswillx.com/deals Get a Free Sample Pack of all LMNT Flavours with your first purchase at https://drinklmnt.com/modernwisdom Get $350 off the Pod 4 Ultra at https://eightsleep.com/modernwisdom (use code MODERNWISDOM) Get a 20% discount on Nomatic's amazing luggage at https://nomatic.com/modernwisdom Get the best bloodwork analysis in America at https://functionhealth.com/modernwisdom Extra Stuff: Get my free reading list of 100 books to read before you die: https://chriswillx.com/books Try my productivity energy drink Neutonic: https://neutonic.com/modernwisdom Episodes You Might Enjoy: #577 - David Goggins - This Is How To Master Your Life: https://tinyurl.com/43hv6y59 #712 - Dr Jordan Peterson - How To Destroy Your Negative Beliefs: https://tinyurl.com/2rtz7avf #700 - Dr Andrew Huberman - The Secret Tools To Hack Your Brain: https://tinyurl.com/3ccn5vkp - Get In Touch: Instagram: https://www.instagram.com/chriswillx Twitter: https://www.twitter.com/chriswillx YouTube: https://www.youtube.com/modernwisdompodcast Email: https://chriswillx.com/contact - Learn more about your ad choices. Visit megaphone.fm/adchoices

Adam is joined by guest hypnotist Cormac Colleran on why focussing on results can lead to breakthroughs in hypnosis. Cormac discusses how he went from working in the pharma industry to being a hypnotherapist obsessed with helping people find the results they want. Cormac talks about addictions and shares a hypnosis demo to help you make a change.  For more information on Cormac visit:  https://www.resultsfocusedhypnosis.com/  Adam and Cormac will both be presenting at the Irish Hypnotherapy Conference in Dublin in April - tickets can be purchased here: https://irishhypnotherapyconference.ie/  Use the code ADAM for a discount on tickets.   More Info on Cormac:   Cormac Colleran Adv. Hip. MIHA ICHI is a vastly experienced Clinical Hypnotherapist and Life Skills Coach. He has dedicated many thousands of hours of his life towards developing, honing and perfecting his hypnotic skills to the point that he is now highly regarded as one of the top young hypnotherapists practicing in Ireland today. “His incredible understanding of how your mind works, allied with his unique ability to consistently connect with clients are what mark him out from his peers.” This unique ability allows him to get directly to the source of the problem (that which is preventing you from moving on and making the changes you want) and guide you quickly and easily to the solutions that's right for you. You will begin to notice the positive feelings straight away. “I've never believed in a one size fits all philosophy, therefore with each and every client I see, I treat everyone as an individual with their own individual circumstances and their own individual needs. This means that you get only the treatment that is tailored to you and is right for you.” It is this philosophy that has allowed Cormac to achieve the phenomenal success he has with his clients. An example of this is his approaching 90% success rate with Quit Smoking clients in ONLY ONE session. Cormac's background includes business development and quality management roles in the Medical Device and Pharmaceutical sectors. He is a highly competent business development coach who understands the process of transformation in both business and people. He is highly professional and approachable. He has a passion for people and a passion for change. Adam's course Hypnotic Wealth can be found here: https://www.adamcox.co.uk/hypnotic-wealth.html  Coming Soon - The Hypnotists's Secret Circle: Adam will soon be launching a new low-cost membership to access his entire hypnosis archive without the intro, outro, and explanation and an exclusive community only for members. In the meantime you can secure a free sleep download here: https://tr.ee/MCuZqKPnEg  Adam Cox is one of the world's most innovative hypnotists and is known for being the hypnotherapist of choice for Celebrities, CEO's and even Royalty. To book a free 30-minute consultation call to consider working with Adam go to: https://go.oncehub.com/AdamCox Adam's rates for hypnotherapy in pounds and US dollars are here: https://www.adamcox.co.uk/hypnotherapist.html  You can contact Adam at adam@adamcox.co.uk Further information on Adam is here: https://linktr.ee/AdamCoxOfficial  Tags: Adam Cox, the hypnotist, NLP, asmr, hypnosis, hypnotherapy, hypnotist, stress, sleep, worry, meditation, guided meditation, hypnotism, anxiety, hypnosis for abundance, hypnosis for confidence hypnosis, Guest Hypnotist John Scanlon, addiction hypnosis,

Brian Clement explores the latest advancements and strategies in longevity. Learn from a pioneer in the field about how to extend your lifespan and enhance your quality of life through innovative health practices. #Longevity #HealthPioneers #LifeExtension

Several provisions in the state's latest budget proposal could leave the Indiana Historical Society without a building. A $3 million project is underway to improve Tarkington Park, just west of the State Fairgrounds. Pharmaceutical giant Eli Lilly announced Wednesday that it plans to invest roughly $27 billion in United States manufacturing. ClearPath465, a project that began in 2022, aims to make the I-465 and I-69 interchange safer and alleviate congestion for drivers on the north east side. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Drew Daudelin, Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

Gemma started her career studying Mechanical Engineering at Cardiff University. She quickly discovered the world of Continuous Improvement and spent 20 years working to improve processes and systems within various manufacturing industries including Automotive, Pharmaceutical, Dairy, Cosmetics & Toiletries, Food, and Medical Devices. She has been a CI Manager numerous times and an Operations Manager running a factory of over 500 people.Gemma is hugely passionate about Improvement and developing people and processes. She gets such a kick out of coaching and facilitating, especially when she sees the lightbulb switch on in someone's head – when they solve a problem; when they realize they have the power to change; or when they get excited about all the improvements they could make.In 2019, Gemma left the world of employment to establish her own business, SPARK Improvement, aiming to switch on as many lightbulbs as possible. Her mission is to help organizations and individuals be the BEST they can be, by helping people SEE, helping people THINK, and helping people CHANGE.Gemma is based in Cheshire in the UK, working globally.www.sparkimprovement.co.ukLink to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Thanks a ton for supporting RP and tuning into the podcast! Want to get even more jacked? Grab the RP Hypertrophy App for your training, and maximize your gym efforts with the RP Diet Coach App to nail your nutrition. We only back what we use—VersaGrips are a game changer. Snag a pair and save 15% w code MIKE15! https://www.versagripps.com/pages/drmike 0:30 GLP-1 and alcohol 3:42 Other benefits of GLP-1 12:30 What if you don't “need” them 14:50 Benefits of GLP-1 list 17:20 Longevity promoting 19:52 Cardiovascular health and blood pressure 25:06 Kidney benefits 26:44 Neuroprotective effects 28:45 Gut issues 32:41 Anti inflammatory 36:27 Gut health 37:18 Mental health 39:26 Bone health, cancer, immune function 41:30 Visceral fat 47:00 Extending use 57:15 Pharmaceutical revolution

Thank you for joining us for another episode of the Low Carb MD Podcast. Tristan Justice is a 27-year-old certified yoga instructor and reporter at The Federalist and co-author of Fat And Unhappy: How “Body Positivity” Is Killing Us (and How to Save Yourself). He is also the author and editor of the Substack, Social Justice Redux which covers issues related to his personal questions surrounding fitness, the integrity of our modern diet, the implications of our lifestyles, and the culture's wide-range approach to these topics.   In this episode, Dr. Brian and Tristan talk about… (00:00) Intro (00:51) Tristan's career and why he wrote his book, Fat and Unhappy (06:35) Fat shaming and how to address obesity and poor metabolic effectively and compassionately (09:15) Tips for those who have become frustrated with their inability to lose weight and feel healthy (12:39) Why the message of ‘you're fine the way you are' is NOT necessarily a positive, empowering message (14:32) The Philly FatCon (18:06) Food addiction and how big food companies deliberately contribute to it (20:22) The Make America Healthy Again movement (23:00) Stigmas, addiction, and GLP-1s (26:26) Pharmaceutical sponsorship of organizations and influencers promoting the body positivity message and exacerbating the metabolic health epidemic (33:48) Dietary propaganda and the obscuring of nutritional reality by big companies with a lot to gain from such misinformation (36:54) The warped incentive structure in healthcare in the United States and how it can be corrected (47:52) The main takeaways of Tristan's book and how to apply the principles of health it contains to your life (48:48) Tristan's Covid lockdown experience and his struggle with addiction to marijuana (52:44) Plugs and Outro   For more information, please see the links below. Thank you for listening!   Links:   Please consider supporting us on Patreon: https://www.lowcarbmd.com/   Resources Mentioned in this Episode: Follow the Science (book): https://www.amazon.com/Follow-Science-Sharyl-Attkisson/dp/0063314916 Chris Palmer's research in the area of Metabolic Psychiatry: https://www.chrispalmermd.com/articles/   Tristan Justice: Fat and Unhappy (book): https://www.amazon.com/Fat-Unhappy-Positivity-Killing-Yourself-ebook/dp/B0DPJCKMNL?ref_=ast_author_mpb X: https://x.com/justicetristan?lang=en Social Justice Redux (Substack): https://socialjusticeredux.substack.com/about   Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author   Dr. Tro Kalayjian:  Website: https://www.doctortro.com/ Twitter: https://twitter.com/DoctorTro Instagram: https://www.instagram.com/doctortro/   Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.    Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://doctortro.com/community/